2型糖尿病(Type 2 Diabetes Mellitus,T2DM)的流行与肥胖引起的机体负荷加重有关,预计在未来20年内全世界将有逾6亿人罹患T2DM。[1] T2DM对患者的生存和生活质量都有很大影响,特别是对于青年时期即确诊的患者。[2] 尽管对于T2DM所有的并发症...
小循整理;参考资料:Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus. A Scientific Statement From the American Heart Association. Circulation. 2020;141. ▼点击下载声明原文
Association of Oxidatively Damaged Mitochondrial Proteins in Adipocyte-Derived Extracellular Vesicles with Heart Failure with Preserved Ejection Fraction in Type 2 Diabetes Patients 2型糖尿病患者脂肪细胞源性细胞外囊中氧化损伤的线粒体蛋白与射血分数保...
Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–2559. doi: 10.1056/NEJMoa0802743. 6. Duckworth W,et al. VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129–139. doi: 10.1056...
Two posted presented at the American Heart Association’s 2024 Scientific Sessions explored empagliflozin among patients with type 2 diabetes and cardiovascular risk. The sodium-glucose cotransporter-2 (SGLT-2) inhibitor empagliflozin could help improve clinical outcomes in patients who hav...
2型糖尿病合并心血管疾病患者服用恩格列净,可使心血管获益 Abstract 4139688: Empagliflozin versus Placebo in Patients with Cardiovascular Disease and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis 据国际糖尿病联盟(IDF)统计,2017年中国糖尿病患病人数达到1.14亿,至2040年,这一数字则可能增至...
这是一类新型抗糖尿病药物。是一种用于降低成年人2型糖尿病血糖的药物。Sotagliflozin(索格列净)是首个用于治疗1型和2型糖尿病的双SGLT2/1抑制剂。) 他的作用机制如何? “People with Type 2 diabetes have higher rates of cardiovascular and kidney disease and more serious complications,” said lead study...
Association of Oxidatively Damaged Mitochondrial Proteins in Adipocyte-Derived Extracellular Vesicles with Heart Failure with Preserved Ejection Fraction in Type 2 Diabetes Patients 2型糖尿病患者脂肪细胞衍生的细胞外囊泡中氧化损伤的线粒体蛋白与射血分数保留型心力衰竭的关系 ...
参考文献： Suzanne V. Arnold, Deepak L. Bhatt, Gregory W. Barsness. Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association.Circulation. 2020;141:00–00. 本文首发丨医学界内分泌频道 本文作者丨辣酱 ...
BPROAD - Effects of Intensive Blood Pressure Control in Patients with Type 2 Diabetes (BPROAD) BPROAD试验:强化血压控制对2型糖尿病患者的影响 SUMMIT - Tirzepatide for Patients With Heart Failure With Preserved Ejection Fraction and Obesity: the SUMMIT Trial ...